Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy.

Authors

  • Rafal Turo St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF
  • Samer Jallad St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF
  • William Richard Cross St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF
  • Stephen Prescott St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF

DOI:

https://doi.org/10.5489/cuaj.175

Keywords:

prostate, prostate cancer, prostate adenocarcinoma, transgender women, transsexual patient, male-to-female sex reassignment

Abstract

The incidence of prostate cancer in transsexual patients is very low with only few reported cases. Many years before presenting with prostate cancer, these patients receive hormone ablation as a part of their gender therapy. Their disease is already defined as castrate resistant, and the treatment and follow-up of such patients remains a challenge. We report a case of a male-to-female transgender woman who was diagnosed with metastatic prostate cancer, 31 years post-feminization.

Downloads

Download data is not yet available.

Author Biographies

Rafal Turo, St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF

Urology Department

Urology Research Fellow

Samer Jallad, St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF

Urology Department

Urology Clinical Fellow

William Richard Cross, St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF

Urology Department

Consultant Urologist

Stephen Prescott, St James University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF

Urology Department

Consultant Urologist

Downloads

Published

2013-08-19

How to Cite

Turo, R., Jallad, S., Cross, W. R., & Prescott, S. (2013). Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy. Canadian Urological Association Journal, 7(7-8), e544–6. https://doi.org/10.5489/cuaj.175

Issue

Section

Case Report